Sacituzumab govitecan shows promise in treating the most aggressive type of breast cancer
Watertown, MA, 2021-Nov-24 — /EPR Network/ — A unique antibody drug conjugate (ADC), which delivers a high dose of a cancer-killing drug to tumor cells [read full press release…]
